Drug Profile
AVD 9991
Latest Information Update: 25 Feb 2005
Price :
$50
*
At a glance
- Originator Imaxio
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 25 Feb 2005 Discontinued - Preclinical for Type-2 diabetes mellitus in France (unspecified route)
- 14 Jul 2003 Preclinical trials in Type-2 diabetes mellitus in France (unspecified route)